• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911316300
Device Problem Occlusion Within Device (1423)
Patient Problems Reocclusion (1985); Ischemic Heart Disease (2493)
Event Date 12/16/2015
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: as the stent was implanted the device will not be returned for evaluation.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as: 2134265-2017-10513 and 2134265-2017-10516.(b)(6) clinical study.It was reported that stent restenosis occurred and the patient experienced coronary heart disease.On (b)(6) 2014, the patient presented with an unstable angina (braunwald classification: iia) and was referred for cardiac catheterization.Subsequently, the index procedure was performed.Target lesion #1 was located in the mid left coronary artery (lad) and was treated by placement of a 2.50x16mm promus element ¿ stent.Target lesion #2 was located in the distal left circumflex artery and was treated by placement of a 3.00x16mm promus element ¿ stent.Target lesion #3 was located in the proximal lad and was treated by placement of a 3.50x20mm promus element ¿ stent.On (b)(6) 2014, the subject was discharged on aspirin and clopidogrel.On (b)(6) 2015, 591 days post index procedure, the patient was diagnosed with coronary atherosclerotic heart disease after unstable angina pectoris restenosis and was hospitalized on the same day.On (b)(6) 2015, coronary angiography was performed which revealed the 1st diagonal (target vessel) was 80% stenosed.It was treated with percutaneous coronary intervention (pci) with 0% residual stenosis.The patient then had a blood transfusion.On (b)(6) 2015, the event was considered to be recovered/resolved and the patient was discharged on the same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6976093
MDR Text Key90203262
Report Number2134265-2017-10515
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCN
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/29/2014
Device Model NumberH7493911316300
Device Catalogue Number39113-1630
Device Lot Number0016087232
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/10/2017
Initial Date FDA Received10/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/23/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
-
-